The Single-use Bioprocessing Market size was estimated USD 9.1 billion in 2022 and is expected to reach USD 41.5 billion by 2030 at a CAGR of 20.9% during the forecast period of 2023-2030.
The single-use bioprocessing market has witnessed significant growth in recent years, driven by the increasing demand for efficient and cost-effective solutions in the biopharmaceutical industry. This innovative approach eliminates the need for traditional stainless-steel equipment, reducing the risk of cross-contamination and improving overall operational efficiency.
One of the key factors contributing to the growth of this market is the rising adoption of single-use technologies by biopharmaceutical manufacturers. These technologies offer several advantages, such as reduced capital investment, faster turnaround times, and enhanced flexibility in manufacturing processes. Moreover, they enable manufacturers to scale up or down production quickly, meeting changing market demands without major disruptions.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/3661
Another driving force behind the expansion of the single-use bioprocessing market is the growing focus on personalized medicine and targeted therapies. As these treatments require smaller batch sizes and more frequent manufacturing cycles, single-use systems provide a perfect solution by offering quick changeover capabilities and minimizing product loss during transitions.
Furthermore, stringent regulations regarding drug safety and quality control have Additionally, the adoption of single-use bioprocessing systems is also driven by the need for cost-effective manufacturing processes. Traditional stainless steel systems require extensive cleaning and validation procedures between batches, which can be time-consuming and expensive. In contrast, single-use systems eliminate the need for cleaning and validation, reducing downtime and overall production costs. Moreover, single-use bioprocessing systems offer enhanced flexibility in terms of facility design and layout. Unlike traditional systems that require fixed infrastructure and dedicated spaces, single-use systems can be easily integrated into existing facilities or set up in modular cleanrooms. This flexibility allows manufacturers to optimize their production space and adapt to changing manufacturing needs more efficiently. Furthermore, the use of single-use systems contributes to sustainability efforts in the biopharmaceutical industry. These systems generate less waste compared to traditional systems, as they eliminate the need for cleaning agents and reduce water and energy consumption. By reducing the environmental footprint of bioprocessing operations, single-use systems align with the industry's growing focus on sustainability and eco-friendly practices. In conclusion, the expansion of the single-use bioprocessing market is driven by various factors, including the ability to scale production quickly, meet personalized medicine requirements, comply with stringent regulations, achieve cost-effectiveness, enhance flexibility in facility design, and contribute to sustainability efforts.
KEY MARKET SEGMENTS
- Work Equipment
- Apparatus & Plants
- Simple & Peripheral Elements
- Upstream Bioprocessing
- Downstream Bioprocessing
By End User
- Biopharmaceutical & Pharmaceutical companies
- Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
- Academic & Research institutes
Major Players Listed in the Report are as Follows:
Sartorius AG, Danaher Corp., Thermo Fisher Scientific, Inc., Merck KGaA, Avantor, Inc., Eppendorf SE, Corning Inc., Boehringer Ingelheim International GmbH, Lonza, Infors AG, PBS Biotech, Inc., and Others.
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)